VisionCare Ophthalmic Technologies

VisionCare Ophthalmic Technologies (VisionCare) is a privately-held development stage company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. The Company has developed and is currently sponsoring clinical trials of the Implantable Miniature Telescope (IMT™ by Dr. Isaac Lipshitz), an ocular prosthetic device designed to improve the central vision of patients who have bilateral moderate to severe central vision loss due to age-related macular degeneration (AMD) and other macular disorders.


Date Type Amount Investors Valuation
01/05/05 Series D 20M Infinity Venture Capital, Israel Infinity Venture Capital, Onset Ventures, Peregrine Ventures, Pitango Venture Capital, Three Arch Partners, Boston Scientific, Clal Industries and Investments Unknown
02/01/11 Series E 13.4M Unknown


Joaquin Wolff (VP Global Marketing & Sales)

Boris Aradovsky (VP Quality Assurance)

Michael Strauss (Board Member)

Eli Aharoni (VP R&D)

Michael Kaplan (Board Member)

View more details about all 6 people at VisionCare Ophthalmic Technologies